Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.1250
+0.0350 (38.89%)
May 16, 2025, 3:08 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Non-invasive Cervical Cancer Detection Device | 98.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non-invasive Cervical Cancer Detection Device Growth | 653.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Major Part Components | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Major Part Components Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Disposables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Disposables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Warranty | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Warranty Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia | 98.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia Growth | 653.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|